Ipragliflozin L‑Proline—also marketed under the trade name Suglat®—is mainly used for the management of type 2 diabetes mellitus (T2DM). Specifically, it’s the L‑proline salt form of ipragliflozin, a sodium‑glucose co‑transporter 2 (SGLT2) inhibitor, providing several therapeutic benefits. It is grouped under the following drug class(es): SGLT2 inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include UNII-M6N3GK48A4, M6N3GK48A4, DTXSID20241771 and Suglat (TN). Its PubChem CID is 57339444.
Ipragliflozin l-proline
| CAS No | 951382-34-6 |
|---|---|
| Molecular Formula | C26H30FNO7S |
| Molecular Weight | 519.6 g/mol |
| Synonyms | (2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;(2S)-pyrrolidine-2-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ipragliflozin L‑Proline—also marketed under the trade name Suglat®—is mainly used for the management of type 2 diabetes mellitus (T2DM). Specifically, it’s the L‑proline salt form of ipragliflozin, a sodium‑glucose co‑transporter 2 (SGLT2) inhibitor, providing several therapeutic benefits.
The listed CAS number is 951382-34-6.
The listed molecular formula is C26H30FNO7S.
The listed molecular weight is 519.6 g/mol.
(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;(2S)-pyrrolidine-2-carboxylic acid.
The source lists UNII-M6N3GK48A4, M6N3GK48A4, DTXSID20241771 and Suglat (TN).